S K AGE Exports — Pyrimethamine Exporter Profile
Indian Pharmaceutical Exporter · #7 for Pyrimethamine · $600.0K export value · DGFT Verified
S K AGE Exports is the #7 Indian exporter of Pyrimethamine with $600.0K in export value and 12 verified shipments. S K AGE Exports holds a 1.3% market share in Pyrimethamine exports across 3 countries. The company exports 9 pharmaceutical products worth $25.0M across 5 therapeutic categories.
S K AGE Exports — Pyrimethamine Export Profile: Buyers & Destinations

Where Does S K AGE Exports Export Pyrimethamine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $1.4M | 28 | 31.6% |
| BURKINA FASO | $650.0K | 13 | 14.7% |
| CHAD | $400.0K | 8 | 9.0% |
| SENEGAL | $400.0K | 8 | 9.0% |
| GHANA | $350.0K | 7 | 7.9% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $300.0K | 6 | 6.8% |
| GAMBIA | $212.8K | 6 | 4.8% |
| ANGOLA | $171.8K | 5 | 3.9% |
| COTE D IVOIRE | $114.4K | 3 | 2.6% |
| TOGO | $108.3K | 3 | 2.4% |
S K AGE Exports exports Pyrimethamine to 19 countries. The largest destination is NIGERIA accounting for 31.6% of S K AGE Exports's Pyrimethamine shipments, followed by BURKINA FASO (14.7%) and CHAD (9.0%). These destinations reflect S K AGE Exports's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pyrimethamine from S K AGE Exports?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | ANGOLA | $3.6M | 79 |
| TO THE ORDER. | SENEGAL | $322.7K | 7 |
| ERRA | GHANA | $250.0K | 5 |
| TO THE ORER | GAMBIA | $140.1K | 4 |
| TO THE ORDER......... | MOZAMBIQUE | $4.2K | 1 |
| TO THE ORDER:::: | SIERRA LEONA | $4.2K | 1 |
S K AGE Exports supplies Pyrimethamine to 6 buyers globally. The largest buyer is TO THE ORDER (ANGOLA), followed by TO THE ORDER. (SENEGAL) and ERRA (GHANA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pyrimethamine Export Value and How Much Does S K AGE Exports Contribute?
India exported $10.6M worth of Pyrimethamine through 411 shipments from 70 suppliers to 46 countries, serving 118 buyers globally. S K AGE Exports contributes $600.0K to this total, accounting for 1.3% of India's Pyrimethamine exports. S K AGE Exports ships Pyrimethamine to 19 countries through 6 buyers.
What Is the Average Shipment Value for S K AGE Exports's Pyrimethamine Exports?
S K AGE Exports's average Pyrimethamine shipment value is $50.0K per consignment, based on 12 shipments totaling $600.0K. The largest destination is NIGERIA (31.6% of S K AGE Exports's Pyrimethamine exports).
How Does S K AGE Exports Compare to Other Indian Pyrimethamine Exporters?
S K AGE Exports ranks #7 among 70 Indian Pyrimethamine exporters with a 1.3% market share. The top 3 exporters are S KANT HEALTHCARE LIMITED ($4.3M), MACLEODS PHARMACEUTICALS LTD ($1.7M), GRACURE PHARMACEUTICALS LIMITED ($818.5K). S K AGE Exports processed 12 shipments to 3 destination countries.
What Pyrimethamine Formulations Does S K AGE Exports Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINES: AMODIAQUINE 150MG +SULFADOXINE/PYRIMETHAMINE 500/25MG DISPERSIBLE TABLETS (SUPYRA DISPERSIBLE) UNITNOS | $450.0K | 9 |
| H/M-AMODIAQUINE 75MG+SULFADOXINE/PYRIMETHAMINE 250/12.5 MG DISPERSIBLE TABLET (SUPYRA DISPERSIBLE JUNIOR) Unit- 50(1+3 | $450.0K | 9 |
| H/M-AMODIAQUINE 150MG +SULFADOXINE/PYRIMETHAMINE 500/25MG DISPERSIBLE TABLETS (SUPYRA DISPERSIBLE) Unit-50(1+3)Co-Blist | $300.0K | 6 |
| HARMLESS MEDICINES AMODIAQUINE 150MG SULFADOXINE PYRIMETHAMINE 500 25MG DISPERSIBLE TABLETS SUPYRA DISPERSIBLE Unit 5 | $150.0K | 3 |
| HARMLESS MEDICINES:AMODIAQUINE 150MG +SULFADOXINE/PYRIMETHAMINE 500/25MG DISPERSIBLE TABLETS (SUPYRA DISPERSIBLE) UNIT-NOS | $150.0K | 3 |
| H/M-AMODIAQUINE 75MG+SULFADOXINE/PYRIMETHAMINE 250/12.5MG DISPERSIBLE TAB(SUPYRADISPERSIBLE JUNIOR)UNIT:50(1+3)CO-BLISTNOS | $150.0K | 3 |
| H/M - AMODIAQUINE 150MG+SULFADOXINE/PYRIMETHAMINE 500/25MG DISPERSIBLE TABLETS (SUPYRA DISPERSIBLE)UNIT:50(1+3)CO-BLISTNOS | $150.0K | 3 |
| AMODIAQUINE 75MG+SULFADOXINE/PYRIMETHAMINE 250/12.5 MG DISPERSIBLE TABLET (SUPYRA DISPERSIBLE JUNIOR) UNIT :50(1+3)CO-BLNOS | $150.0K | 3 |
| HARMLESS MEDICINE AMODIAQUINE 150MG +SULFADOXINE/PYRIMETHAMINE 500/25MG DISPERSIBLE TABLETS (SUPYRA DISPERSIBLE) UNIT :5NOS | $150.0K | 3 |
| H/M-AMODIAQUINE 150MG +SULFADOXINE/PYRIMETHAMINE 500/25MG DISPERSIBLE TABLETS (SUPYRA DISPERSIBLE) Unit-50(1+3)Co-Blist | $150.0K | 3 |
S K AGE Exports exports 53 distinct Pyrimethamine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINES: AMODIAQUINE 150MG +SULFADOXINE/PYRIMETHA with 9 shipments worth $450.0K.
Regulatory Requirements: Exporting Pyrimethamine to Key Markets
What S K AGE Exports must comply with to export Pyrimethamine to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does S K AGE Exports Compare to Nearest Pyrimethamine Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $750.0K | 15 | 4 | $50.0K |
| 5 | MEDOPHARM | $700.0K | 14 | 4 | $50.0K |
| 7 | S K AGE EXPORTS ★ | $600.0K | 12 | 3 | $50.0K |
| 9 | SHALINA LABORATORIES PRIVATE LIMITED | $574.8K | 38 | 9 | $15.1K |
| 10 | MEDOPHARM PRIVATE LIMITED | $262.7K | 14 | 1 | $18.8K |
S K AGE Exports ranks #7 among 70 Indian Pyrimethamine exporters. Average shipment value of $50.0K compared to the market average of $151.1K. The closest competitors by value are FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED and MEDOPHARM.
Which Indian Ports Ship Pyrimethamine Exports?
| Port | Shipments | % Share |
|---|---|---|
| JNPT/ NHAVA SHEVA SEA | 57 | 13.9% |
| SAHAR AIR | 50 | 12.2% |
| NHAVA SHEVA SEA (INNSA1) | 49 | 11.9% |
| JNPT | 41 | 10.0% |
| NHAVA SHEVA | 35 | 8.5% |
| CHENNAI SEA (INMAA1) | 21 | 5.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 18 | 4.4% |
| KAMARAJAR PORT (INENR1) | 16 | 3.9% |
What Other Antimalarial & Antiparasitic Products Does S K AGE Exports Export?
S K AGE Exports also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on S K AGE Exports's Pyrimethamine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like S K AGE Exports. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times. These disruptions have resulted in freight inflation, with transport charges doubling and surcharges ranging from $4,000 to $8,000 per shipment. (pharmaceuticalcommerce.com) Such logistical challenges can impact the timely delivery of pharmaceuticals, particularly to markets in the Middle East and North Africa.
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. India supplies 47% of the US's generic drugs, underscoring its critical role in the American healthcare system. (orfonline.org) However, the imposition of tariffs on Indian pharmaceutical products by the US poses a risk, potentially leading to reduced export volumes and increased compliance costs. (transdatanexus.com)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures. Indian exporters must ensure adherence to these regulations to maintain market access. The India–EFTA Trade and Economic Partnership Agreement, effective from October 1, 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries, potentially enhancing market opportunities for exporters like S K AGE Exports. (en.wikipedia.org)
S K AGE Exports — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing facilities as of 2024. (ibef.org) Instances of non-compliance have decreased, indicating improved adherence to quality standards. For S K AGE Exports, maintaining such compliance is essential to ensure uninterrupted market access and to uphold the company's reputation in the global pharmaceutical industry.
About S K AGE Exports
S K AGE Exports exports 9 products worth $25.0M. Beyond Pyrimethamine, top products include Artemether, Clotrimazole, Gentamicin, Erythromycin, Sulfadoxine. View the complete S K AGE Exports profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pyrimethamine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pyrimethamine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: S K AGE Exports matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 99 individual customs records matching S K AGE Exports exporting Pyrimethamine, covering 53 formulations to 19 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 46+ countries, 118+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pyrimethamine Export Data from S K AGE Exports
Access shipment-level details, pricing data, buyer connections, and competitive analysis for S K AGE Exports's Pyrimethamine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
S K AGE Exports
Full Company Profile →
9 products · $25.0M total trade · 5 categories
Pyrimethamine Stats
Company Overview
Top Products by S K AGE Exports
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for S K AGE Exports.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pyrimethamine. For current shipment-level data, contact TransData Nexus.